Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infections in Tlaxcala, Mexico

Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) are widely recognised as two prevalent sexually transmitted infections that can have detrimental effects on women’s reproductive health. Previous research has concentrated on studying high-risk populations, resulting in limited epidemiologica...

Full description

Saved in:
Bibliographic Details
Published in:Epidemiology and infection 2023-11, Vol.151, p.e198-e198, Article e198
Main Authors: Meneses-León, Joacim, Hernández-López, Rubí, Hernández-Salazar, Sonia, Torres-Ibarra, Leticia, Rivera-Paredez, Berenice, León-Maldonado, Leith, Magis-Rodríguez, Carlos, Lazcano-Ponce, Eduardo, Salmerón, Jorge
Format: Article
Language:English
Subjects:
Age groups
Asymptomatic
Birth control
Cancer screening
Cervical cancer
Cervix
Chlamydia
Chlamydia Infections - epidemiology
Chlamydia trachomatis
College students
Confidence intervals
Early Detection of Cancer
Enzymes
Epidemiology
Female
Gonorrhea
Gonorrhea - diagnosis
Gonorrhea - epidemiology
Gynecology
Health services
Humans
Immunoassay
Infections
Informed consent
Intrauterine devices
IUD
Jurisdiction
Medical screening
Mexico - epidemiology
Neisseria gonorrhoeae
Nucleic acids
Population studies
Prevalence
Public health
Reproductive health
Sexually transmitted diseases
Short Paper
STD
Uterine Cervical Neoplasms
Womens health
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) are widely recognised as two prevalent sexually transmitted infections that can have detrimental effects on women’s reproductive health. Previous research has concentrated on studying high-risk populations, resulting in limited epidemiological data regarding the general population. Therefore, the objective of this study was to estimate the prevalence of CT and NG among women attending public primary health care in Tlaxcala, Mexico. The study sample included 2,396 women already participating in the cervical cancer screening programme, from July to November 2014. After obtaining informed consent, the CT and NG tests were conducted on cervical samples, using a nucleic acid amplification test. We estimate the prevalence with 95% confidence intervals (CIs). Women who tested positive were promptly notified and provided with appropriate treatment. In our study population, CT and NG prevalences were 3.2 (95% CI: 2.6–4.0) and 0.01 (95% CI: 0.01–0.03), respectively. CT prevalence was higher in younger women (age 
ISSN:0950-2688
1469-4409
DOI:10.1017/S0950268823001899